Dr. Lawson to Present ISET Lecture on Humacyte's Bioengineered Blood Vessel Replacement
January 26, 2015—Humacyte, Inc., announced that Jeffrey H. Lawson, MD, who serves as a clinical consultant for the company, is a keynote speaker at ISET 2015: the 27th International Symposium on Endovascular Therapy, which will be held January 31 to February 4 in Hollywood, Florida. Dr. Lawson collaborated with the company on preclinical and clinical studies, and is a principal investigator for Humacyte’s clinical study of the company’s off-the-shelf human bioengineered blood vessel replacement product in patients with end-stage renal disease (ESRD).
